| Neurodevelopmental effects of prenatal exposure to psychotropic medications. | |
| | |
MedLine Citation:
|
PMID: 20583298 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Until now, studies on the reproductive safety of psychotropics have typically assessed the risk of congenital malformations and perinatal complications associated with in utero exposure to such medications. However, little is known of their inherent potential neurobehavioral teratogenicity. The objective is to analyze available data from studies investigating developmental outcome of children exposed prenatally to psychotropics. A computerized Medline/PubMed/TOXNET/ENBASE search (1960-2010) was conducted using the following keywords: pregnancy, child/infant development/neurodevelopment, antidepressants, benzodiazepines, mood stabilizers, and antipsychotics. A separate search was also run to complete the safety profile of single specific medications. Resultant articles were cross-referenced for other relevant articles not identified in the initial search. A noncomputerized review of pertinent journals and textbooks was also performed. All studies published in English and reporting primary data on the developmental outcome of infants exposed in utero to psychotropics and born without malformations were collected. As regards antiepileptic drugs, only studies that provided data on specific medications approved for psychiatric practice use (carbamazepine, lamotrigine, and valproate) were considered. Data were extracted from 41 articles (38 identified electronically and 3 nonelectronically), which met the inclusion criteria. Despite reviewed studies showing relevant methodological limitations, concordant, albeit preliminary, information seems to exclude that prenatal exposure to both selective serotonin reuptake inhibitors and tricyclic antidepressants may interfere with the infants' psychological and cognitive development. Conversely, information on valproate strongly discourages its use in pregnant women. Moreover, although data on carbamazepine remain controversial, information on whole classes of drugs and single medications is either absent (second-generation antipsychotics) or too limited (first-generation antipsychotics, benzodiazepines, lithium, and lamotrigine) to inform the decision-making process. For all classes of psychotropics, new and/or further studies are warranted to answer definitively the urgent question about the impact of prenatal exposure to such medications on infant development. |
| | |
Authors:
|
Salvatore Gentile |
Related Documents
:
|
14521478 - Pharmacotherapy to limit weight gain caused by antipsychotic use. 10100918 - Catatonia under medication with risperidone in a 61-year-old patient. 14513928 - Neuropsychiatric consequences (atypical psychosis and complex-partial seizures) of ecst... 18394168 - Cost of antipsychotic polypharmacy in the treatment of schizophrenia. 1564508 - Medical education and the challenge of neurological disability. 17238438 - Paper versus electronic documentation in complex chronic illness: a comparison. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Depression and anxiety Volume: 27 ISSN: 1520-6394 ISO Abbreviation: Depress Anxiety Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-12 Completed Date: 2010-10-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9708816 Medline TA: Depress Anxiety Country: United States |
Other Details:
|
Languages: eng Pagination: 675-86 Citation Subset: IM |
Copyright Information:
|
2010 Wiley-Liss, Inc. |
Affiliation:
|
Department of Mental Health, ASL "Salerno", Mental Health Center, Cava de' Tirreni, Salerno, Italy. salvatore_gentile@alice.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Brain
/
drug effects,
growth & development Child Child Development / drug effects* Child, Preschool Cognition Female Humans Infant Mental Disorders / drug therapy Pregnancy Pregnancy Complications / drug therapy, psychology Prenatal Exposure Delayed Effects* Psychotropic Drugs / adverse effects* |
| Chemical | |
Reg. No./Substance:
|
0/Psychotropic Drugs |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion.
Next Document: Functional analysis of the HGSNAT gene in patients with mucopolysaccharidosis IIIC (Sanfilippo C Syn...